![Serum immunofixation electrophoresis revealed an IgG kappa monoclonal... | Download High-Resolution Scientific Diagram Serum immunofixation electrophoresis revealed an IgG kappa monoclonal... | Download High-Resolution Scientific Diagram](https://www.researchgate.net/publication/319053468/figure/fig3/AS:526069440540672@1502436136379/Serum-immunofixation-electrophoresis-revealed-an-IgG-kappa-monoclonal-proteinFigure-2A.png)
Serum immunofixation electrophoresis revealed an IgG kappa monoclonal... | Download High-Resolution Scientific Diagram
![Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants | Nature Communications Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-28324-6/MediaObjects/41467_2022_28324_Fig1_HTML.png)
Structural and biochemical rationale for enhanced spike protein fitness in delta and kappa SARS-CoV-2 variants | Nature Communications
![Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS](https://www.pnas.org/cms/10.1073/pnas.1901734117/asset/3df9a166-9499-4800-a9f7-49e5fac85081/assets/graphic/pnas.1901734117fig01.jpeg)
Kappa-on-Heavy (KoH) bodies are a distinct class of fully-human antibody-like therapeutic agents with antigen-binding properties | PNAS
![Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation](http://www.scielo.org.za/img/revistas/samj/v109n10/08f01.jpg)
Laboratory testing in the evaluation of a monoclonal protein: A practical framework for interpretation
![SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci](https://www.prosci-inc.com/wp-content/uploads/2021/12/SARS-CoV-2-COVID-19-full-length-Spike-S1-Kappa-India-Dec-2020-B-1-617-1-Variant-Recombinant-Protein_SDS_21-823.jpg)
SARS-CoV-2 (COVID-19) full-length Spike Kappa (India, Dec 2020) B.1.617.1 Variant Recombinant Protein - Cat. No. 21-823 | ProSci
![Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists](https://www.frontiersin.org/files/Articles/447554/fphar-10-00407-HTML/image_m/fphar-10-00407-g001.jpg)
Frontiers | A Review of the Therapeutic Potential of Recently Developed G Protein-Biased Kappa Agonists
![Serum protein electrophoresis in both patients. Case 1 shows a 34 g/L... | Download Scientific Diagram Serum protein electrophoresis in both patients. Case 1 shows a 34 g/L... | Download Scientific Diagram](https://www.researchgate.net/publication/344151355/figure/fig1/AS:952588862242817@1604126291215/Serum-protein-electrophoresis-in-both-patients-Case-1-shows-a-34-g-L-IgG-kappa_Q640.jpg)